Ophthalmic Bevacizumab Reaches Critical Review Stage In EU

3D illustration of BEVACIZUMAB title on a medical document
The EMA is reviewing a marketing application for an ophthalmic formulation of bevacizumab • Source: Alamy

More from Review Pathways

More from Pathways & Standards